|
Nutrient, substance, food or food category
|
Claim
|
Conditions of use of the claim
|
Conditions and/or restrictions of use of the food and/or additional statement or warning
|
EFSA opinion reference
|
Commission Regulation
|
| Sugar-free chewing gum |
Sugar-free chewing gum helps neutralise plaque acids. Plaque acids are a risk factor in the development of dental caries. |
Information shall be given to the consumer that the beneficial effect is obtained with chewing of 2-3 g of sugar-free chewing gum for 20 minutes, at least three times per day after meals. |
|
Q-2010-00120  |
Commission Regulation (EU) No 665/2011 |
| Sugar-free chewing gum |
Sugar-free chewing gum helps reduce tooth demineralisation. Tooth demineralisation is a risk factor in the development of dental caries. |
Information shall be given to the consumer that the beneficial effect is obtained with chewing of 2-3 g of sugar-free chewing gum for 20 minutes, at least three times per day after meals. |
|
Q-2010-00119 |
Commission Regulation (EU) No 665/2011 |
| Plant sterols/Plant stanol esters |
Plant sterols and plant stanol esters have been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease. |
Information to the consumer that the beneficial effect is obtained with a daily intake of 1,5-2,4 g plant sterols/stanols. Reference to the magnitude of the effect may only be made for foods within the following categories: yellow fat spreads, dairy products, mayonnaise and salad dressings. When referring to the magnitude of the effect, the entire range ‘7 to 10 %’ and the duration to obtain the effect ‘in 2 to 3 weeks’ must be communicated to the consumer |
|
Q-2008-779 |
Commission Regulation (EC) No 384/2010 of 5/05/2010 |
| Oat beta-glucan |
Oat beta-glucan has been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease. |
Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 3 g of oat beta-glucan.
The claim can be used for foods which provide at least 1g of oat beta glucan per quantified portion. |
|
Q-2008-681 |
Commission Regulation (EU) No 1160/2011 of 14 November 2011 |
| Plant sterols: Sterols extracted from plants, free or esterified with food grade fatty acids. |
Plant sterols have been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease. |
Information to the consumer that the beneficial effect is obtained with a daily intake of 1,5-2,4 g plant sterols. Reference to the magnitude of the effect may only be made for foods within the following categories: yellow fat spreads, dairy products, mayonnaise and salad dressings. When referring to the magnitude of the effect, the entire range “7 to 10 %” and the duration to obtain the effect “in 2 to 3 weeks” must be communicated to the consumer. |
|
Q-2008-085 |
Commission Regulation (EC) No 983/2009 of 21/10/2009
Amended by Commission Regulation (EU) No 376/2010 of 3/05/2010
|
| Plant stanol esters |
Plant stanol esters have been shown to lower/reduce blood cholesterol. High cholesterol is a risk factor in the development of coronary heart disease. |
Information to the consumer that the beneficial effect is obtained with a daily intake of 1,5-2,4 g plant stanols. Reference to the magnitude of the effect may only be made for foods within the following categories: yellow fat spreads, dairy products, mayonnaise and salad dressings. When referring to the magnitude of the effect, the entire range “7 to 10 %” and the duration to obtain the effect “in 2 to 3 weeks” must be communicated to the consumer. |
|
Q-2008-118 |
Commission Regulation (EC) No 983/2009 of 21/10/2009
Amended by Commission Regulation (EU) No 376/2010 of 3/05/2010 |
| Chewing gum sweetened with 100% xylitol |
Chewing gum sweetened with 100% xylitol has been shown to reduce dental plaque. High content/level of dental plaque is a risk factor in the development of caries in children |
Information to the consumer that the beneficial effect is obtained with a consumption of 2-3g of chewing gum sweetened with 100% xylitol at least 3 times per day after the meals |
|
Q-2008-321 |
Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
|
Nutrient, substance, food or food category
|
Claim
|
Conditions of use of the claim
|
Conditions and/or restrictions of use of the food and/or additional statement or warning
|
EFSA opinion reference
|
Commission Regulation
|
| α-linolenic acid (ALA) & linoleic acid (LA), essential fatty acids |
Essential fatty acids are needed for normal growth and development of children. |
Information to the consumer that the beneficial effect is obtained with a daily intake of 2 g of α-linolenic acid (ALA) and a daily intake of 10 g of linoleic acid (LA). |
|
Q-2008-079 |
Commission Regulation (EC) No 983/2009 of 21/10/2009
Amended by Commission Regulation (EU) No 376/2010 of 3/05/2010
|
| Calcium and vitamin D |
Calcium and vitamin D are needed for normal growth and development of bone in children. |
The claim can be used only for food which is at least a source of calcium and vitamin D as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation 1924/2006. |
|
Q-2008-116 |
Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Docosahexaenoic acid (DHA) |
Docosahexaenoic acid (DHA) intake contributes to the normal visual development of infants up to 12 months of age. |
Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 100 mg of DHA. When the claim is used on follow-on formula, the food shall contain at least 0,3 % of the total fatty acids as DHA. |
|
Q-2008-211
Q- 2008-688
Q-2008 -689
|
Commission Regulation (EU) No 440/2011 of 6 May 2011
|
| Docosahexaenoic acid (DHA) |
Docosahexaenoic acid (DHA) maternal intake contributes to the normal development of the eye of the foetus and breastfed infants |
Information shall be given to pregnant and lactating women that the beneficial effect is obtained with a daily intake of 200 mg of DHA in addition to the recommended daily intake for omega-3 fatty acids for adults, i.e. 250 mg DHA and eicosapentaenoic acid (EPA). The claim can be used only for food which provides a daily intake of at least 200 mg DHA. |
|
Q-2008-675 |
Commission Regulation (EU) No 440/2011 of 6 May 2011 |
| Docosahexaenoic acid (DHA) |
Docosahexaenoic acid (DHA) maternal intake contributes to the normal brain development of the foetus and breastfed infants. |
Information shall be given to pregnant and lactating women that the beneficial effect is obtained with a daily intake of 200 mg of DHA in addition to the recommended daily intake for omega-3 fatty acids for adults, i.e. 250 mg DHA and EPA. The claim can be used only for food which provides a daily intake of at least 200 mg DHA |
|
Q-2008-773 |
Commission Regulation (EU) No 440/2011 of 6 May 2011 |
| Calcium |
Calcium is needed for normal growth and development of bone in children. |
The claim can be used only for food which is at least a source of calcium as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation 1924/2006. |
|
Q-2008-322 |
Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Vitamin D |
Vitamin D is needed for normal growth and development of bone in children. |
The claim can be used only for food which is at least a source of Vitamin D as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation 1924/2006. |
|
Q-2008-323 |
Commission Regulation (EC) No 983/2009 of 21/10/2009 |
| Phosphorus |
Phosphorus is needed for the normal growth and development of bone in children. |
The claim can be used only for food which is at least a source of phosphorus as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation 1924/2006 |
|
Q-2008-217 |
Commission Regulation (EC) No 1024/2009 of 29/10/2009 |
| Iodine |
Iodine contributes to the normal growth of children |
The claim can be used only for food which is at least a source of iodine as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006 |
|
Q-2008-324 |
COMMISSION REGULATION (EU) No 957/2010 of 22 October 2010 |
| Iron |
Iron contributes to normal cognitive development of children |
The claim can be used only for food which is at least a source of iron as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006 |
|
Q-2008-325 |
COMMISSION REGULATION (EU) No 957/2010 of 22 October 2010 |
| Protein |
Protein is needed for normal growth and development of bone in children. |
The claim can be used only for food which is at least a source of protein as referred to in the claim SOURCE OF PROTEIN as listed in the Annex to Regulation 1924/2006. |
|
Q-2008-326 |
Commission Regulation (EC) No 983/2009 of 21/10/2009 |
|
Nutrient, substance, food or food category
|
Claim
|
Conditions of use of the claim
|
Conditions and/or restrictions of use of the food and/or additional statement or warning
|
EFSA opinion reference
|
Commission Decision
|
| Water-soluble tomato concentrate (WSTC I and II) |
Water-Soluble Tomato Concentrate (WSTC) I and II helps maintain normal platelet aggregation, which contributes to healthy blood flow |
Information to the consumer that the beneficial effect is obtained with a daily consumption of 3g WSTC I or 150mg WSTC II in up to 250ml of either fruit juices, flavoured drinks or yogurt drinks (unless heavily pasteurised) or with a daily consumption of 3 g WSTC I or 150 mg WSTC II in food supplements when taken with a glass of water or other liquid. |
|
Q-2009-00229 and Q-2010-00809 |
Commission Decision 2009/980/EU Amended by Commission Decision 2010/770/EU |
Article 14(1)(a) health claims referring to the reduction of a risk factor in the development of a disease
